Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Magellan Pharmacy Services, Inc. $200 Million Term Loan Facility
Davis Polk advised the administrative agent in connection with a $200 million term loan facility (the “Credit Facility”) for…
McKesson formation of a new company with Change Healthcare Holdings
Davis Polk advised McKesson Corporation on its creation of a new health care information technology company, which will…
Medtronic Acquires HeartWare International
Davis Polk is advising Perella Weinberg as financial adviser to HeartWare International, Inc. in connection with its $1.1…
Universal American Corp. $115 Million Convertible Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Universal American Corp. of an…
Global Blood Therapeutics, Inc. Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $120 million follow-on offering of common stock of…
Spark Therapeutics Follow-On Offering
Davis Polk advised the representative of the underwriters in connection with the $181 million public offering of 4,025,000…
Nevro Corp. $172.5 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the several underwriters, in connection with an SEC-registered offering by Nevro…
The Medicines Company $402.5 Million Convertible Senior Notes Offering
Davis Polk advised the joint bookrunners in connection with a Rule 144A offering by The Medicines Company of $402.5 million…
Davis Polk Advises Aetna on Its $13 Billion Senior Notes Offering
Davis Polk advised Aetna Inc. on its SEC-registered notes offering of $13 billion aggregate principal amount of senior notes…
Mylan N.V. $6.5 Billion Notes Offering
Davis Polk advised the representatives of the initial purchasers on Rule 144A/Regulation S offerings by Mylan N.V. (“Mylan”)…